SCOPUS 정보 검색 플랫폼

Annals of Pharmacotherapy

Volumn 36, Issue 7-8, 2002, Pages 1183-1192

Darbepoetin alfa: A novel erythropoiesis-stimulating protein

(3) Joy, Melanie S a Da Camara, Carlos C a Perreault, Marc M a

a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE (United States)

Author keywords

Darbepoetin alfa; Erythropoiesis stimulating protein

Indexed keywords

NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; DRUG DERIVATIVE; ERYTHROPOIETIN;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHRONIC KIDNEY DISEASE; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DIALYSIS; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; ERYTHROPOIESIS; HEALTH CARE UTILIZATION; HEMOGLOBIN DETERMINATION; HUMAN; MEDICAL LITERATURE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; ANEMIA; ANIMAL; AREA UNDER THE CURVE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; HALF LIFE TIME; MALE; METABOLIC CLEARANCE RATE; METABOLISM; MOUSE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ADULT; ANEMIA; ANIMALS; AREA UNDER CURVE; CHILD; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN; FEMALE; HALF-LIFE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC CLEARANCE RATE; MICE; RANDOMIZED CONTROLLED TRIALS;

EID: 0036020184 PISSN: 10600280 EISSN: None Source Type: Journal
DOI: 10.1345/aph.1A416 Document Type: Article

Times cited : (43)

References (56)

1
- 0033054185
- Normalizing hematocrit in dialysis patients improves brain function
- (1999) Am J Kidney Dis , vol.33 , pp. 1122-1130
- Pickett, J.L.¹ Theberge, D.C.² Brown, W.S.³

2
- 0033008861
- Physical functioning and exercise capacity in patients on dialysis
- (1999) Adv Renal Replace Ther , vol.69 , pp. 141-148
- Johansen, K.¹

3
- 0032739951
- A preliminary, study of the effects of correction of anemia with recombinant erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (the SLEEPO Study)
- (1999) Am J Kidney Dis , vol.34 , pp. 1089-1095
- Benz, R.L.¹ Pressman, M.R.² Hovick, E.T.³ Peterson, D.D.⁴

4
- 0033930935
- The impact of anemia correction on cardiovascular disease in end-stage renal disease
- (2000) Semin Nephrol , vol.20 , pp. 350-355
- Murphy, S.T.¹ Parfrey, P.S.²

5
- 0001817480
- Updates in chronic renal failure and hemodialysis
- Carter BL, et al. eds. Kansas City: American College of Clinical Pharmacy
- (1999) Pharmacotherapy self assessment program. 3rd ed. , pp. 1-48
- Stamatakis, M.K.¹ Joy, M.S.²

6
- 0023837516
- Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney
- (1988) J Clin Invest , vol.81 , pp. 620-623
- Lacombe, C.¹ Da Silva, J.L.² Bruneval, P.³ Fournier, J.F.⁴ Wendling, F.⁵ Casadevall, N.⁶

7
- 0025912710
- Localization of cells producing erythropoietin in murine liver by in situ hybridization
- (1991) Blood , vol.77 , pp. 2497-2503
- Koury, S.T.¹ Bondurant, M.C.² Koury, M.J.³ Semenza, G.L.⁴

8
- 0033968567
- Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients
- (2000) J Am Soc Nephrol , vol.11 , pp. 335-342
- Moreno, F.¹ Sanz-Guajardo, D.² Manuel, J.³ Lopez-Gomez, J.M.⁴ Jofre, R.⁵ Valderrabano, F.⁶

9
- 0031044609
- Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
- (1997) J Clin Oncol , vol.15 , pp. 1218-1234
- Glaspy, J.¹ Bukowski, R.² Steinberg, D.³ Taylor, C.⁴ Tchekmedyian, S.⁵ Vadhan-Raj, S.⁶

10
- 0003444198
- Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, April
- (1998) USRDS 1998 annual data report

11
- 0002929285
- Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy
- (1995) Cancer J Sci Am , vol.1 , pp. 252-260
- Henry, D.H.¹ Brooks, B.J.² Case, D.C.³ Fishkin, E.⁴ Jacobson, R.⁵ Keller, A.M.⁶

12
- 0028074548
- Prediction of response to erythropoietin treatment in chronic anemia of cancer
- (1994) Blood , vol.84 , pp. 1056-1063
- Ludwig, H.¹ Fritz, E.² Leitgeb, C.³ Pecherstorfer, M.⁴ Samonigg, H.⁵ Schuster, J.⁶

13
- 0031964226
- Clinical guidelines for the treatment of cancer-related anemia
- (1998) Pharmacotherapy , vol.18 , pp. 156-169
- Koeller, J.M.¹

14
- 0009763055
- Thousand Oaks, CA: Amgen, November 14
- (1996) Package insert. Epogen (recombinant human erythropoietin)

15
- 0030921662
- NKF-DOQI clinical practice guidelines for anemia of chronic renal failure. National Kidney Foundation - Dialysis Outcomes Quality Initiative
- (1997) Am J Kidney Dis , vol.30 , Issue.4 SUPPL. 3

16
- 0242611254
- Cloning and expression of the human erythropoietin gene
- (1985) Proc Natl Acad Sci , vol.82 , pp. 7580-7584
- Lin, F.K.¹ Suggs, S.² Lin, C.H.³ Browne, J.K.⁴ Smalling, R.⁵ Egrie, J.C.⁶

17
- 0000212930
- The role of carbohydrate on the biological activity of EPO
- (1993) Glycoconjugate J , vol.10 , pp. 263
- Egrie, J.C.¹ Grant, J.R.² Gillies, D.K.³ Aoki, K.H.⁴ Strickland, T.W.⁵

18
- 0002418073
- Novel erythropoiesis stimulating protein (NESP) has a longer serum half-life and greater in vivo biological activity than recombinant human erythropoietin (r-Hu-EPO)
- (1997) Blood , vol.90 , Issue.10 SUPPL. 1 , pp. 243
- Egrie, J.C.¹ Dwyer, E.² Lykos, M.³ Hitz, A.⁴ Browne, J.K.⁵

19
- 0034997401
- Development and characterization of novel erythropoiesis stimulating-protein (NESP)
- (2001) Br J Cancer , vol.84 , Issue.SUPPL. 1 , pp. 3-10
- Egrie, J.C.¹ Browne, J.K.²

20
- 0032737391
- Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients
- (1999) J Am Soc Nephrol , vol.10 , pp. 2392-2395
- Macdougall, I.C.¹ Gray, S.J.² Elston, O.³ Breen, C.⁴ Jenkins, B.⁵ Browne, J.⁶

21
- 0000488626
- The pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in pediatric patients with chronic renal failure (CRF) or endstage renal disease
- (2000) J Am Soc Nephrol , vol.11
- Lerner, G.R.¹ Kale, A.S.² Warady, B.A.³ Jabs, K.L.⁴ Bunchman, T.E.⁵ Maroni, B.J.⁶

22
- 0027310385
- Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis
- (1993) Am J Kidney Dis , vol.21 , pp. 635-642
- Ateshkadi, A.¹ Johnson, C.A.² Oxton, L.L.³ Hammond, T.G.⁴ Bohenek, W.S.⁵ Zimmerman, S.W.⁶

23
- 0025986687
- Pharmacokinetics of recombinant human erythropoietin in children with renal failure
- (1991) Nephrol Dial Transplant , vol.6 , pp. 709-714
- Evans, J.H.C.¹ Brocklebank, J.T.² Bowmer, C.J.³ Ng, P.C.⁴

24
- 0001846602
- Novel erythropoiesis stimulating protein (NESP) exhibits a prolonged serum half life (T1/2) in oncology patients (pts)
- (2000) Proc ASCO , vol.19
- Glaspy, J.¹ Colowick, A.² Heatherington, A.³

25
- 0034997274
- Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: Preliminary report
- (2001) Br J Cancer , vol.84 , Issue.SUPPL. 1 , pp. 11-16
- Heatherington, A.C.¹ Schuller, J.² Mercer, A.J.³

26
- 0002980754
- Predictability of pharmacokinetic properties of NESP administered once every 3 weeks in patients with nonmyeloid malignancies receiving cyclic chemotherapy
- (2001) Proc ASCO , vol.20
- Heatherington, A.¹ Rovetti, R.² Kotasek, D.³ Glaspy, J.⁴ Colowick, A.⁵

27
- 0001545680
- The pharmacokinetics of novel erythropoiesis stimulating protein (NESP) following chronic intravenous administration is time-and dose-linear
- (2000) J Am Soc Nephrol , vol.11
- Allon, M.¹ Kleinman, K.² Walczyk, M.³ Kaupke, C.⁴ Maroni, B.J.⁵ Heatherington, A.⁶

28
- 0000206617
- Novel erythropoiesis stimulating protein (NESP) for the treatment of renal anemia
- (1998) J Am Soc Nephrol , vol.9 , pp. 258-259
- Macdougall, I.C.¹

29
- 0001724535
- Novel erythropoiesis stimulating protein (NESP) corrects anemia in dialysis patients when administered at reduced dose frequency compared with recombinant-human erythropoietin (r-HuEPO)
- (2000) J Am Soc Nephrol , vol.11
- Coyne, D.¹ Ling, B.N.² Toto, R.³ McDermott-Vitak, A.D.⁴ Trotman, M.L.⁵ Jackson, L.⁶

30
- 0000203171
- Novel erythropoiesis stimulating protein (NESP) maintains hemoglobin (hgb) in ESRD patients when administered once weekly or once every other week
- (1999) J Am Soc Nephrol , vol.10
- Vanrenterghem, Y.¹ Barany, P.² Mann, J.³

31
- 0034919301
- Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency
- (2001) Kidney Int , vol.60 , pp. 741-747
- Locatelli, F.¹ Olivares, J.² Walker, R.³ Wilkie, M.⁴ Jenkins, B.⁵ Dewey, C.⁶

32
- 0001075198
- Novel erythropoiesis stimulating protein (NESP) administered once every other week corrects anemia in patients with early chronic kidney disease
- (2001) J Am Soc Nephrol , vol.12 , pp. 364
- Suranyi, M.¹ Walker, R.² Jackson, L.³ Feaster, J.⁴ McDermott-Vitak, A.⁵

33
- 0001524646
- Novel erythropoiesis stimulating protein (NESP) safely maintains hemoglobin concentration levels in hemodialysis patients as effectively as r-HuEPO when administered once weekly
- (2000) J Am Soc Nephrol , vol.11
- Nissenson, A.R.¹ Swan, S.K.² Lindberg, J.S.³ Soroka, S.D.⁴ McDermott-Vitak, A.D.⁵ Wang, C.⁶

34
- 0000978972
- Novel erythropoiesis stimulating protein (NESP) effectively maintains hemoglobin (Hgb) when administered at a reduced dose frequency compared with recombinant human erythropoietin (r-HuEPO) in ESRD patients
- (2000) J Am Soc Nephrol , vol.11
- Graf, H.¹ Lacombe, J.-L.² Braun, J.³ Gomes da Costa, A.A.⁴

35
- 0001075199
- Novel erythropoiesis stimulating protein (NESP) administered once every 3 weeks by the intravenous or subcutaneous route maintains hemoglobin (Hgb) in dialysis patients
- (2001) J Am Soc Nephrol , vol.12
- Vanrenterghem, Y.¹ Jadoul, M.² Foret, M.³ Walker, R.⁴

36
- 0009788780
- Novel erythropoiesis stimulating protein (NESP) effectively maintains hemoglobin when administered at a reduced dose frequency compared with recombinant human erythropoietin (r-HuEPO) in dialysis patients in Mexico
- (2001) J Am Soc Nephrol , vol.12
- Bochicchio, T.¹ Correa-Rotter, R.² Trinidad, R.P.³ Trevino, B.A.⁴ Feaster, J.⁵ Husain, I.⁶

37
- 0035021354
- A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multi-cycle chemotherapy
- (2001) Br J Cancer , vol.84 , Issue.SUPPL. 1 , pp. 17-23
- Glaspy, J.¹ Jadeja, J.S.² Justice, G.³ Kessler, J.⁴ Rischards, D.⁵ Schwartzberg, L.⁶

38
- 0000679267
- A randomized, blinded, placebo-controlled, Phase II, dose-finding study of NESP in patients with lymphoproliferative malignancies
- (2001) Proc ASCO , vol.20
- Hedenus, M.¹ Hansen, S.² Dewey, C.³ Watson, D.⁴ Colowick, A.⁵ Osterborg, A.⁶

39
- 0000380627
- Open-label, Phase I/II dose escalation study of NESP in patients with chronic anemia of cancer
- (2001) Eur J Cancer , vol.37 , Issue.SUPPL. 6 , pp. 355
- Smith, R.¹ Meza, L.² Tchekmedyian, S.³ Chan, D.⁴ Jaiyesimi, I.⁵ Fleishman, A.⁶

40
- 0000909549
- Randomized, active-controlled, Phase I/II, dose-escalation study of NESP administered weekly and every 2 weeks in patients with solid tumors
- (2001) Proc ASCO , vol.20
- Glaspy, J.¹ Jadeja, J.² Justice, G.³ Kessler, J.⁴ Richards, D.⁵ Schwarrzberg, L.⁶

41
- 0000405510
- A Phase double-blind, placebo-controlled, randomized study of novel erythropoiesis stimulating protein (NESP) in patients undergoing platinum-treatment for lung cancer
- (2001) Eur J Cancer , vol.37 , Issue.SUPPL. 6 , pp. 264
- Pirker, R.¹ Vansteenkiste, J.² Gateley, J.³ Yates, P.⁴ Colowick, A.⁵ Musil J. III⁶

42
- 0035000303
- Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer
- (2001) Br J Cancer , vol.84 , Issue.SUPPL. 1 , pp. 24-30
- Smith, R.E.¹ Jaiyesimi, I.A.² Meza, L.A.³ Tchekmedyian, N.S.⁴ Chan, D.⁵ Griffith, H.⁶

43
- 0001637369
- Randomized, active-controlled, phase I/II, dose-comparison study of NESP administered weekly or every 2 weeks in patients with solid tumors
- (2001) Eur J Cancer , vol.37 , Issue.SUPPL. 6 , pp. 353
- Glaspy, J.¹ Jadeja, J.² Justice, G.³ Kessler, J.⁴ Richards, D.⁵ Schwartzberg, L.⁶

44
- 0009785344
- Thousand Oaks, CA: Amgen, September 17
- (2001) Package insert. (Aranesp)

45
- 0033913634
- Novel erythropoiesis stimulating protein
- (2000) Semin Nephrol , vol.20 , pp. 375-381
- Macdougall, I.C.¹

46
- 0028153345
- Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis
- (1994) Kidney Int , vol.46 , pp. 1397-1403
- Julian, B.A.¹ Gaston, R.S.² Barker, C.V.³ Krystal, G.⁴ Diethelm, A.G.⁵ Curtis, J.J.⁶

47
- 0024393650
- Worsening of anemia by angiotensin-converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients
- (1989) J Cardiovasc Pharmacol , vol.13 , Issue.SUPPL. 3
- Onoyama, K.¹ Sanai, T.² Motomura, K.³ Fujishima, M.⁴

48
- 0034042547
- ACE inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients
- (2000) Am J Kidney Dis , vol.35 , pp. 1076-1082
- Abu-Alfa, A.K.¹ Cruz, D.² Perazella, M.A.³ Mahnensmith, R.L.⁴ Simon, D.⁵ Bia, M.J.⁶

49
- 0031971365
- Potential angiotensin-converting enzyme inhibitor-epoetin alfa interaction in patients receiving chronic hemodialysis
- (1998) Pharmacotherapy , vol.18 , pp. 627-630
- Schwenk, M.H.¹ Jumani, A.Q.² Rosenberg, C.R.³ Kulogowski, J.E.⁴ Charytan, C.⁵ Spinowitz, B.S.⁶

50
- 0029819150
- Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?
- (1996) Am J Kidney Dis , vol.28 , pp. 535-540
- Cruz, D.N.¹ Perazella, M.A.² Abu-Alfa, A.K.³ Mahnensmith, R.L.⁴

51
- 0028008866
- High hematocrit in haemodialysis patients can be controlled by theophylline administration
- (1994) Nephrol Dial Transplant , vol.9 , pp. 189-191
- Vereerstraeten, A.¹ Gastaldello, K.² Gervy, C.³ Vanherweghem, J.L.⁴ Tielemans, C.⁵

52
- 0025057941
- Amphotericin B blunts erythropoietin response to anemia
- (1990) J Infect Dis , vol.161 , pp. 348-351
- Lin, A.C.¹ Goldwasser, E.² Bernard, E.M.³ Chapman, S.W.⁴

53
- 0035228407
- K/DOQI clinical practice guidelines for anemia of chronic kidney disease, 2000
- (2001) Am J Kidney Dis , vol.37 , Issue.1 SUPPL.

54
- 0003396541
- Montvale, NJ: Medical Economics Company, Aranesp
- (2002) Drug topics red book , pp. 213

55
- 0009762717
- Montvale, NJ: Medical Economics Company
- (2002) Procrit. 2002 Drug topics red book , pp. 506

56
- 0009782449
- Montvale, NJ: Medical Economics Company
- (2002) Epogen. 2002 Drug topics red book: update 2000 , pp. 328

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.